Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Protein Research > Fms-related tyrosine kinase 3 ligand
Fms-related tyrosine kinase 3 ligand buy - large image1
Fms-related tyrosine kinase 3 ligand buy - image1

Fms-related tyrosine kinase 3 ligand

Unit Price: Get Latest Price
Content:

98%

Port:

Nanjing

Packaging:

10μg/bottle

Price valid (until):

2024-12-31

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

semaglutide,Liraglutide,Tirzepatide,PDRN,GABA,Ergothioneine

  • Product Description

  • Seller Information

  • Description


      INTRODUCTION


    Fms-related tyrosine kinase 3 ligand (Flt3L) is a growth factor that stimulates the proliferation and differentiation of hematopoietic stem cells by binding with other growth factors and promotes the expansion of NK cells and dendritic cell subsets. Flt3L is produced by T cells and stromal fibroblasts and targets various cells, including hematopoietic stem cells, B cells, T cells, dendritic cells, and NK cells. Flt3L binds to the homologous receptor tyrosine kinase Flt3 and activates the JAK/STAT signaling pathway.

    Flt3L is a hematopoietic four-helix bundle cytokine that is structurally homologous to stem cell factor (SCF) and colony-stimulating factor 1 (CSF-1). It contains four conserved cysteines and two glycosylation sites. The extracellular portion of Flt3L is approximately 160 amino acid residues in length, while the cytoplasmic segment is about 20-30 amino acid residues long.

    Items Specifications
    Purity  >95%
    Endotoxin  <0.2 EU/μg
    Titer  >1 x 106units/mg

    Basic Info
    Product Name:

    Fms-related tyrosine kinase 3 ligand (Flt3L),Human,Recombinant

    Categories:

    Protein Research

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    semaglutide,Liraglutide,Tirzepatide,PDRN,GABA,Ergothioneine

    Location:

    Building C5, No.9 Weidi Road, Xianlin University Town, Xianlin Street, Qixia District, Nanjing City, Jiangsu Province

    Payment Terms:

    TT against copy of documents,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    30

    Total Annual Revenue:

    $25 million-$50 million

    Total Employees:

    201-300

    Year of Establishment:

    2017

  • Country Product Purchase Quantity Date Posted
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.